Psychiatry
Panic Disorder
Evaluate acute cardiopulmonary, respiratory, toxicologic, and substance-related mimics before diagnosing panic disorder. Confirm recurrent unexpected attacks plus persistent concern or avoidance, then select disorder-focused CBT, an SSRI or SNRI, or both according to severity, preference, access, and comorbidity.
Emergency assessment
Do not diagnose panic disorder before excluding acute medical illness
Stabilize and investigate according to the presenting symptom complex rather than attributing chest pain or dyspnea to anxiety.
For an acute episode with chest discomfort, dyspnea, wheeze, syncope, or marked autonomic symptoms, perform a focused cardiopulmonary and substance-exposure assessment before making a psychiatric diagnosis. Emergency evaluation may include point-of-care lung ultrasonography, bedside chest radiography, and peak flowmetry to identify respiratory abnormalities; obtain toxicology screening when drug misuse or intoxication is plausible. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
A panic attack has abrupt onset, peaks within 10 minutes, and is characterized by at least 4 physical or cognitive symptoms; an episode commonly lasts about 1 hour. This temporal pattern supports, but does not establish, a panic diagnosis because acute medical disorders can present with similar symptoms. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
After acute physical causes have been evaluated, document the event phenotype, triggers, frequency, avoidance, current medications, and substance use. A symptom score can quantify burden but cannot replace medical exclusion or longitudinal diagnostic assessment. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
Use bedside lung ultrasonography, chest radiography, and peak flowmetry when respiratory pathology is in the acute differential. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
Order toxicology screening when stimulant, other substance, or medication-related symptoms are possible. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
Do not use a brief emergency presentation alone to establish the longitudinal persistence criterion for panic disorder. PubMed+1PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMC
| Presentation pattern | Immediate diagnostic action | Interpretation and next step |
|---|---|---|
| Dyspnea, wheeze, or suspected respiratory abnormality | Point-of-care lung ultrasonography, bedside chest radiography, and peak flowmetry. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ... | Treat or further evaluate identified respiratory disease; diagnose panic disorder only after physical causes are addressed. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ... |
| Symptoms with possible substance exposure | Toxicology screening. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ... | If exposure is identified, assess a substance- or medication-related cause before assigning primary panic disorder. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ... |
| Abrupt fear with autonomic and cognitive symptoms | Characterize onset, peak, symptom count, recurrence, and post-attack behavior. PubMed+1PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMC | Rapid peak supports a panic attack phenotype; recurrent unexpected attacks plus persistent sequelae are required for panic disorder. PubMed+1PubMedClinical Practice Guidelines for Assessment and Management of ...PubMedPanic Disorder: Current Research and Management Approaches - PMC |
Longitudinal diagnosis
Confirm panic disorder and separate agoraphobic avoidance
The diagnostic pivot is recurrence of unexpected attacks followed by durable concern or behavior change.
Diagnose panic disorder when recurrent unexpected panic attacks are accompanied by at least 1 month of persistent concern, worry, or behavioral change related to attacks. The post-attack persistence requirement distinguishes a recurrent disorder from an isolated panic attack. PubMedPubMedPanic Disorder: Current Research and Management Approaches - PMC
Assess agoraphobia separately. DSM-5 distinguishes agoraphobia from panic disorder, so document avoidance and its functional effect rather than treating agoraphobic behavior as automatically establishing panic disorder. PubMedPubMedPanic Disorder: Current Research and Management Approaches - PMC
Measure baseline severity with the Panic Disorder Severity Scale, Panic Disorder Self-Report, Panic and Agoraphobia Scale, NIMH Panic Questionnaire, or Panic-Associated Symptoms Scale. The Panic Disorder Severity Scale is among tools identified for physician use in emergency and primary-care settings. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
Record whether attacks are unexpected versus situationally cued; the disorder criterion specifies recurrent unexpected attacks. PubMedPubMedPanic Disorder: Current Research and Management Approaches - PMC
Ask whether attack-related concern, catastrophic worry, or avoidance has persisted for at least 1 month. PubMedPubMedPanic Disorder: Current Research and Management Approaches - PMC
Document agoraphobia as a separate diagnostic and treatment target. PubMedPubMedPanic Disorder: Current Research and Management Approaches - PMC
Definitive treatment
Choose CBT, first-line antidepressant therapy, or both
Select treatment by patient preference, access, symptom burden, avoidance, comorbidity, and prior treatment response.
Offer cognitive behavioral therapy as an evidence-based treatment pathway. In a systematic review and meta-analysis of 69 randomized trials involving 4,118 outpatients with anxiety-related disorders, CBT was associated with better panic-disorder outcomes than control conditions after treatment and at 1 to 6 months and 6 to 12 months of follow-up; reported Hedges g values for panic disorder were 0.22 to 0.35. JAMAJAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and
When medication is chosen, use an SSRI or SNRI as first-line pharmacotherapy. An umbrella review of antipsychotic agents in anxiety disorders reports that treatment guidelines recommend SSRIs or SNRIs first line, whereas benzodiazepines, TCAs, and other agents are not first-line pharmacotherapy. WileyWileyAntipsychotic agents in anxiety disorders: An umbrella review
For patients preferring psychodynamic treatment or unable to engage in CBT, panic-focused psychodynamic psychotherapy has randomized-trial evidence versus applied relaxation training, but its comparative effectiveness against CBT and medications remains unresolved. NEJMNEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician Do not substitute an untested modality for CBT or a first-line antidepressant without clarifying that evidence limitation.
Use CBT when the patient prefers psychotherapy, has prominent avoidance, or wants a nonpharmacologic first-line option; outcomes remained superior to control conditions through 12 months after completion. JAMAJAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and
Use an SSRI or SNRI when pharmacotherapy is preferred or indicated by clinical context; reassess tolerability and response rather than escalating to non-first-line classes by default. WileyWileyAntipsychotic agents in anxiety disorders: An umbrella review
Consider panic-focused psychodynamic psychotherapy as an alternative psychotherapy option, while counseling that direct comparisons with CBT and medications are needed. NEJMNEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician
| Clinical situation | Preferred next step | Key tradeoff |
|---|---|---|
| Patient prefers psychotherapy or has a strong avoidance target | Offer CBT. JAMAJAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and | CBT showed benefit versus control conditions through 6 to 12 months after treatment completion. JAMAJAMALong-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and |
| Patient prefers medication or requires pharmacotherapy | Start an SSRI or SNRI as first-line pharmacotherapy. WileyWileyAntipsychotic agents in anxiety disorders: An umbrella review | Monitor response and tolerability before moving to non-first-line medication classes. WileyWileyAntipsychotic agents in anxiety disorders: An umbrella review |
| CBT is unavailable, unacceptable, or not feasible | Discuss panic-focused psychodynamic psychotherapy as an alternative. NEJMNEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician | Evidence exists versus applied relaxation training, but comparative evidence against CBT and medications is still needed. NEJMNEJMPsychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician |
| Considering antipsychotic, benzodiazepine, or TCA as initial treatment | Reassess the treatment plan; these are not identified as first-line pharmacotherapy in guideline summaries. WileyWileyAntipsychotic agents in anxiety disorders: An umbrella review | Reserve non-first-line approaches for individualized circumstances rather than routine initial management. WileyWileyAntipsychotic agents in anxiety disorders: An umbrella review |
Avoid reflexive antipsychotic use
Do not use an antipsychotic as routine first-line pharmacotherapy for panic disorder. Guideline recommendations summarized in an umbrella review place SSRIs and SNRIs first line and classify benzodiazepines, TCAs, and other agents outside that first-line position. WileyWileyAntipsychotic agents in anxiety disorders: An umbrella review
Follow-up
Measure response and reassess the diagnosis before changing treatment
Track attack burden, anticipatory anxiety, avoidance, function, adverse effects, adherence, and alternative explanations at each treatment decision.
Use the same structured measure at baseline and follow-up when possible, particularly the Panic Disorder Severity Scale or a panic-specific self-report instrument. This makes change in panic frequency, symptom burden, and agoraphobic avoidance visible rather than relying solely on an unstructured global impression. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
When response is inadequate, first reassess adherence, diagnostic accuracy, and comorbidities before changing therapy. Across adult depression guidelines, this sequence was a common initial recommendation for inadequate first-line treatment and is a useful safeguard against premature medication switching in patients with persistent panic-like symptoms. BMJBMJQuality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Open
Reopen the medical differential when the symptom pattern changes, new cardiopulmonary or respiratory findings emerge, or substance exposure becomes plausible. Repeat targeted evaluation rather than attributing all subsequent episodes to a prior panic diagnosis. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
At each visit, record panic frequency, attack-related worry, avoidance, function, treatment adherence, and adverse effects using a consistent instrument. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
Before declaring treatment failure, reassess diagnosis, adherence, and comorbid conditions. BMJBMJQuality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Open
Escalate or repeat medical evaluation for a changed acute phenotype rather than assuming recurrence of panic disorder. PubMedPubMedClinical Practice Guidelines for Assessment and Management of ...
References
- [PDF] NDA 215455 - FDA — www.fda.gov · www.fda.gov
- [PDF] Prozac (fluoxetine hydrochloride) 10 mg, 20 ... - accessdata.fda.gov — www.accessdata.fda.gov · www.accessdata.fda.gov
- Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review | BMJ Open — bmjopen.bmj.com · bmjopen.bmj.com
- Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and — jamanetwork.com · jamanetwork.com
- Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses — bmjopen.bmj.com · bmjopen.bmj.com
- Psychodynamic Psychotherapy for Panic Disorder? | NEJM Clinician — clinician.nejm.org · clinician.nejm.org
- Screening for Anxiety in Adolescent and Adult Women - ACP Journals — www.acpjournals.org · www.acpjournals.org
- Management of Chronic Insomnia Disorder in Adults - ACP Journals — www.acpjournals.org · www.acpjournals.org
- The quality and clinical applicability of recommendations in anxiety disorders guidelines: A systematic review of seventeen guidelines from seven countries - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Couple therapy and systemic interventions for adult‐focused ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Panic Disorder and Migraine: Comorbidity, Mechanisms, and ... — headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
- The identification and psychological treatment of panic disorder in ... — acamh.onlinelibrary.wiley.com · acamh.onlinelibrary.wiley.com
- Antipsychotic agents in anxiety disorders: An umbrella review — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- A Network Analysis of Panic Disorder, Agoraphobia, and ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Evaluating the efficacy of psychological therapies for generalised ... — acamh.onlinelibrary.wiley.com · acamh.onlinelibrary.wiley.com
- Diagnosis and treatment of patients with bipolar disorder — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Cardiac Anxiety - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Table A4, Characteristics of Included Guidelines - Yoga for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Abuse: A Review of the Clinical Effectiveness and Guidelines - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Table 1, Current clinical practice guidelines for the treatment of child and adolescent DDs - Treatment of Depression in Children and Adolescents: A Systematic Review - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Table 4, Characteristics of Included Guidelines - Short-Term Psychodynamic Psychotherapy for the Treatment of Mental Illness: A Review of Clinical Effectiveness and Guidelines - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents - PMC — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Clinical Practice Guidelines for Assessment and Management of ... — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Panic Disorder: Current Research and Management Approaches - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov